ArticleJournal of intensive care2026
In-hospital development of new-onset frailty and discharge outcomes among patients with sepsis: a Korean multicenter registry study.
Article in Journal of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundFrailty is an important marker of vulnerability and poor outcomes in patients with sepsis. Although prior studies have primarily focused on pre-existing frailty or post-discharge outcomes, little is known about the in-hospital development of frailty among patients who are non-frail at baseline.
methodsWe conducted a multicenter cohort study using the Korean Sepsis Alliance registry, a prospectively maintained database of adult patients with sepsis across 15 hospitals in South Korea. Analyses were restricted to patients without baseline frailty, defined as a premorbid Clinical Frailty Scale score < 5. The primary analysis categorized patients as remaining non-frail at discharge, having new-onset frailty at discharge, or dying during hospitalization. Multinomial logistic regression with prespecified covariates was used to evaluate clinical factors associated with these mutually exclusive outcomes, with in-hospital death treated as a competing outcome. Among hospital survivors, discharge destination was described according to discharge frailty status. In an exploratory analysis restricted to patients with new-onset frailty, we evaluated clinical factors associated with home discharge.
resultsAmong 6336 patients without baseline frailty, 1453 (22.9%) had new-onset frailty and 1527 (24.1%) died during hospitalization. Older age (per 1-SD increase, adjusted odds ratio [aOR], 1.38), higher Charlson Comorbidity Index (per 1-SD increase, aOR, 1.27), higher Sequential Organ Failure Assessment score (per 1-SD increase, aOR, 1.41), intensive care unit admission (aOR, 1.47), and pulmonary infection (aOR, 1.77) were associated after adjustment with new-onset frailty (all p < 0.001). Several of these factors were also associated with in-hospital death, with a larger adjusted estimate for SOFA score. Among hospital survivors with new-onset frailty, 42.8% were discharged home. In exploratory analyses restricted to patients with new-onset frailty, higher Sequential Organ Failure Assessment score, solid malignancy, and nursing home- or nursing hospital-acquired infection were associated with a lower likelihood of home discharge. In sensitivity analyses using inverse probability of censoring weighting, the overall pattern of associations for new-onset frailty remained generally consistent.
conclusionsNew-onset frailty and in-hospital death were common among patients with sepsis who were non-frail at baseline. Assessment of frailty at admission and discharge may help characterize functional decline and inform discharge planning after sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.